Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Towa Pharmaceutical said on January 20 that the Intellectual Property High Court upheld a lower court ruling that rejected Swiss-based Debiopharm International SA’s claim that the Japanese generic major infringed its patents for the anticancer agent Elplat (oxaliplatin). Debiopharm filed…
To read the full story
Related Article
- Towa Wins Top Court Victory over Elplat Patent
May 14, 2018
- Debiopharm Brings Towa before Supreme Court over Elplat
March 14, 2017
- Towa Prevails in Patent Suit over Elplat
April 1, 2016
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





